Home Newsfeeds JP Morgan Maintains Neutral on Omnicell, Lowers Price Target to $57

JP Morgan Maintains Neutral on Omnicell, Lowers Price Target to $57

JP Morgan analyst Anne Samuel maintains Omnicell (NASDAQ:OMCL) with a Neutral and lowers the price target from $140 to $57.

byBenzinga Newsdesk

November 18, 2022

1 minute read

JP Morgan analyst Anne Samuel maintains Omnicell (NASDAQ:OMCL) with a Neutral and lowers the price target from $140 to $57.

Analyst Ratings

10 Analysts Have This to Say About NextEra Energy Partners

By Benzinga Insights

June 23, 2:00 PM

Over the past 3 months, 10 analysts have published their opinion on NextEra Energy Partners (NYSE:NEP) stock. These…

NEP

FDA Removes Regulatory Overhang From Inhibikase Therapeutics Parkinson, Atrophy Program

By Vandana Singh

March 8, 12:41 PM

The FDA lifted the full Clinical Hold on Inhibikase Therapeutics Inc’s (NASDAQ:IKT) IkT-148009, the company’s c-Abl inhibitor, in Multiple System…

IKT

Palantir CEO Alex Karp Touts Profitability, Artificial Intelligence Advantage, Acquisition Interest Following Q4 Earnings

By Adam Eckert

February 13, 8:29 PM

Palantir Technologies Inc (NYSE: PLTR) shares soared in Monday's after-hours session as the data software company's surprise leap into profitability outshined its poor guidance.

MSFT

W&T Offshore Q4 EPS $0.10 Beats $0.06 Estimate, Sales $189.70M Beat $182.38M Estimate

By Benzinga Newsdesk

March 7, 5:47 PM

W&T Offshore (NYSE:WTI) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.06 by 66.67 percent. This is unchanged from the same period last year. The company reported

WTI

JP Morgan Maintains Neutral on Omnicell, Lowers Price Target to $57

Related Posts

10 Analysts Have This to Say About NextEra Energy Partners

FDA Removes Regulatory Overhang From Inhibikase Therapeutics Parkinson, Atrophy Program

Palantir CEO Alex Karp Touts Profitability, Artificial Intelligence Advantage, Acquisition Interest Following Q4 Earnings

W&T Offshore Q4 EPS $0.10 Beats $0.06 Estimate, Sales $189.70M Beat $182.38M Estimate